MetaCap

Cue Biopharma Inc. Company Profile

NASDAQ: CUEHealth CareBiotechnology: Pharmaceutical PreparationsUSD

4.15-0.35 (-7.78%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Cue Biopharma at a glance

Cue Biopharma Inc. (NASDAQ: CUE) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Boston, MA. Cue Biopharma is led by Dr. Shao-Lee Lin M.D., Ph.D. and employs about 29 people. The company's shares have traded publicly since 2018.

At a market capitalization of $34.7 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001645460, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Cue Biopharma do?

Cue Biopharma, Inc., a clinical-stage therapeutics company, focuses on developing various therapies for immunological disorders. The company's lead asset is CUE-221, an anti-IgE antibody with a dual-mechanism of action currently in Phase 2 development for allergic diseases. It also developed the Immuno-STAT platform, which targets disease-specific T cells in vivo without broad immune modulation. The company's lead autoimmune candidate is CUE-401, a bifunctional IL-2 and TGF-B program that is advancing towards Phase 1 development to regulate inflammation and drive Treg-mediated tolerance. The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. Cue Biopharma, Inc. was incorporated in 2014 and is headquartered in Boston, Massachusetts.

Business description based on the company's public filings.

Company information

Legal name
Cue Biopharma Inc.
Ticker
NASDAQ: CUE
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. Shao-Lee Lin M.D., Ph.D.
Employees
29
Headquarters
40 Guest Street, Boston, MA, United States
Phone
617 949 2680
IPO year
2018
Market cap
$34.69M
SEC CIK
0001645460
Latest annual report
10-K · Mar 16, 2026

Companies similar to Cue Biopharma

CUE peer companies
CompanyPrice% ChgMarket capCompare
GRCEGrace Therapeutics Inc.1.71-0.58%$35.97Mvs CUE
VERUVeru Inc.1.94-8.06%$33.08Mvs CUE
ATNMActinium Pharmaceuticals Inc. (Delaware)1.05-1.87%$33.01Mvs CUE
HYFTMindWalk Holdings Corp.0.6844-14.27%$32.56Mvs CUE
PLRXPliant Therapeutics Inc.0.5951-4.02%$36.89Mvs CUE
SDEVStablecoin Development Corporation0.50-10.30%$36.90Mvs CUE
GRDXGridAI Technologies Corp.3.16-8.41%$32.44Mvs CUE
FLNAFilana Therapeutics Inc.0.6413+14.52%$32.26Mvs CUE

Related